Example: Heart Attack

Clinical Trials on Chiari Malformation Type 2

Total 54 results

NCT03295864

Active, not recruiting

Arnold Chiari Malformation: the Otological Assessment as an Objective Criteria for Surgical Treatment

Conditions: Arnold-Chiari Malformation, Type 1
NCT04073667

Recruiting

Investigation of the Effects of Exercise Program in Patients With Chiari Type 1 Malformation

Conditions: Arnold Chiari Malformation
NCT02532322

Withdrawn

Efficacy of Acetaminophen in Posterior Fossa Surgery

Conditions: Arnold-Chiari Malformation; Posterior Fossa Tumors
NCT03544970

Completed

An Audit of the Posterior Fossa Characterization in Open Spina Bifida Based on Tertiary Center Experience

Conditions: Fetal Anomaly; Spinal Dysraphism; Chiari Malformation Type 2
NCT00004738

Completed

Genetic Analysis of the Chiari I Malformation

Conditions: Syringomyelia; Type I Arnold Chiari Malformation
NCT02009709

Unknown status

Study of the Safety and Effectiveness of Collagen Cross-Linking at an Irradiance of 9 mW/cm2 and 18 mW/cm2

Conditions: Keratoconus; Corneal Ectasia
NCT02989402

Recruiting

A Phase IV Study to Evaluate Safety, Tolerability and Effectiveness of Rivastigmine Patch 15cm2 in Patients With Severe Dementia of the Alzheimer's Type.

Conditions: Alzheimer's Disease
NCT01737762

Completed

Study Investigating the Safety and Efficacy of HP802-247 in the Treatment of Venous Leg Ulcers >12 cm2 to ≤ 36 cm2

Conditions: Venous Leg Ulcers
NCT02120456

Completed

Safety and Efficacy of Escalating Doses of LEO 43204 Applied Once Daily for Two Consecutive Days on Approximately 250 cm2 on Trunk and Extremities in Subjects With Actinic Keratosis

Conditions: Actinic Keratosis
NCT00731224

Completed

Compliance and Tolerability of Rivastigmine Transdermal Patch 10 cm² in Patients With Probable Alzheimer's Disease.

Conditions: Alzheimer's Disease
NCT01998984

Completed

Efficacy and Safety of Ingenol Mebutate Gel 0.06% When Applied Once Daily for 2, 3 or 4 Consecutive Days to a Treatment Area of Approximately 250 cm2 on Trunk and Extremities in Subjects With Actinic Keratosis

Conditions: Actinic Keratosis
NCT00659893

Completed

Safety and Toleration of PEP005 Topical Gel When Applied to a Treatment Area of up to 100cm2

Conditions: Actinic Keratosis
NCT01957722

Recruiting

NOVOCART®3D for Treatment of Articular Cartilage of the Knee

Conditions: Articular Cartilage of the Femoral Condyle Between 2-6cm2
NCT02669836

Completed

Posterior Fossa Decompression With or Without Duraplasty for Chiari Type I Malformation With Syringomyelia

Conditions: Arnold-Chiari Malformation, Type 1; Chiari Malformation Type I; Type I Arnold-Chiari Malformation; Syringomyelia
NCT04356703

Completed

Fetoscopic Open Spina Bifida Repair Using the SAFER Technique

Conditions: Open Spina Bifida; Myelomeningocele; Meningomyelocele; Chiari Malformation With Spina Bifida; Chiari Malformation Type 2
NCT01667770

Unknown status

Dural Graft Equivalent Comparison Trial

Conditions: Chiari Malformation
NCT04105192

Completed

Effectiveness of a Natural Ingredient on Obesity

Conditions: Overweight and Obesity; High Blood Pressure
NCT03816709

Completed

Intramuscular Heating Rates of a Chattanooga Intelect XT Therapeutic Ultrasound

Conditions: Ultrasound Therapy; Complications
NCT02762253

Terminated

Study of the Safety and Effectiveness of Photochemically Induced Collagen Cross-Linking in Eyes With Keratoconus.

Conditions: Keratoconus
NCT02361216

Completed

Efficacy and Safety of Ingenol Mebutate Gel for Actinic Keratosis Applied on Large Area on Face, Scalp or Chest

Conditions: Actinic Keratosis
NCT03575780

Completed

Single-Center Study Evaluating Systemic Exposure and Safety of KX2-391 Ointment 1% on the Face or Balding Scalp in Subjects With Actinic Keratosis

Conditions: Actinic Keratoses
NCT01922050

Completed

A Study of Increasing Strengths, Safety and Efficacy of Two Formulas of LEO 43204 on the Face or the Chest in Patients With Actinic Keratosis

Conditions: Actinic Keratosis
NCT01761526

Completed

Study to Evaluate the Pharmacokinetics (PK), Safety, Tolerability of Single-Dose Transdermal Rotigotine in Japanese and Caucasian Healthy Male / Female Subjects

Conditions: Healthy
NCT01059903

Completed

Study in Healthy Volunteers to Prove That Two Different Formulations of Rotigotine Patches Deliver Equivalent Drug Amount to the Body

Conditions: Healthy Volunteers
NCT01820260

Completed

Safety and Efficacy of Doses of Ingenol Mebutate Once Daily for Two or Three Consecutive Days in Subjects With Actinic Keratosis

Conditions: Actinic Keratosis